APO-BILASTINE TABLETS 20 MG
BILASTINE : 20 MG · DIN 02549883 · APOTEX INC
Health Canada status: MARKETED
What is APO-BILASTINE TABLETS?
APO-BILASTINE TABLETS 20 MG contains BILASTINE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02549883, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-Oct-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-BILASTINE TABLETS used for?
APO-BILASTINE ORODISPERSIBLE TABLETS (bilastine), APO-BILASTINE TABLETS (bilastine) and APO-BILASTINE ORAL SOLUTION (bilastine) are indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) in patients 4 years of age and older with a body weight of at least 16 kg. APO-BILASTINE ORODISPERSIBLE TABLETS (bilastine), APO-BILASTINE TABLETS (bilastine) and APO-BILASTINE ORAL SOLUTION (bilastine) are indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and hives), in patients 4 years of age and older with a body weight of at least 16 kg.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02549883 |
|---|---|
| Brand name | APO-BILASTINE TABLETS |
| Generic / active ingredient | BILASTINE : 20 MG |
| Manufacturer | APOTEX INC |
| Strength | 20 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | R06AX OTHER ANTIHISTAMINES FOR SYSTEMIC USE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Oct-2024 |
How is it stored and handled?
null
How is it supplied?
10 mg orodispersible tablets: blister packs containing 10 tablets. Cartons contain 30 tablets. 20 mg tablets: blister packs containing 10 tablets. Cartons contains 30 tablets. 2.5 mg/mL oral solution: amber glass bottle containing 120 mL oral solution.
What can be used instead?
Other Canadian products sharing ATC code R06AX OTHER ANTIHISTAMINES FOR SYSTEMIC USE. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-BILASTINE ORAL SOLUTION | 2.5 MG | SOLUTION | APOTEX INC | APPROVED | DIN 02549867 |
| APO-BILASTINE ORODISPERSIBLE TABLETS | 10 MG | TABLET (ORALLY DISINTEGRATING) | APOTEX INC | APPROVED | DIN 02549875 |
Who else supplies OTHER ANTIHISTAMINES FOR SYSTEMIC USE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER ANTIHISTAMINES FOR SYSTEMIC USE appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.